Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall.
Danieli M, Barretta F, Radaelli S, Fiore M, Sangalli C, Barisella M, Palassini E, Miceli R, Frezza AM, Callegaro D, Collini P, Casali PG, Stacchiotti S, Gronchi A. Danieli M, et al. Among authors: frezza am. Cancer. 2023 Nov 1;129(21):3417-3429. doi: 10.1002/cncr.34945. Epub 2023 Jul 15. Cancer. 2023. PMID: 37452607
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
Santini D, Vincenzi B, Addeo R, Garufi C, Masi G, Scartozzi M, Mancuso A, Frezza AM, Venditti O, Imperatori M, Schiavon G, Bronte G, Cicero G, Recine F, Maiello E, Cascinu S, Russo A, Falcone A, Tonini G. Santini D, et al. Among authors: frezza am. Ann Oncol. 2017 Nov 1;28(11):2906. doi: 10.1093/annonc/mdw551. Ann Oncol. 2017. PMID: 28327895 Free article. No abstract available.
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients.
Vincenzi B, Santini D, Perrone G, Graziano F, Loupakis F, Schiavon G, Frezza AM, Ruzzo AM, Rizzo S, Crucitti P, Galluzzo S, Zoccoli A, Rabitti C, Muda AO, Russo A, Falcone A, Tonini G. Vincenzi B, et al. Among authors: frezza am. J Cell Physiol. 2012 Mar;227(3):927-33. doi: 10.1002/jcp.22801. J Cell Physiol. 2012. PMID: 21503888
Classic Kaposi Sarcoma: to treat or not to treat?
Vincenzi B, D'Onofrio L, Frezza AM, Grasso RF, Fausti V, Santini D, Dei Tos AP, Tonini G. Vincenzi B, et al. Among authors: frezza am. BMC Res Notes. 2015 Apr 10;8:138. doi: 10.1186/s13104-015-1076-1. BMC Res Notes. 2015. PMID: 25889316 Free PMC article.
Docetaxel induced pericardial effusion.
Vincenzi B, Santini D, Frezza AM, Rocci L, Tonini G. Vincenzi B, et al. Among authors: frezza am. J Exp Clin Cancer Res. 2007 Sep;26(3):417-20. J Exp Clin Cancer Res. 2007. PMID: 17987805
New therapies in soft tissue sarcoma.
Vincenzi B, Frezza AM, Santini D, Tonini G. Vincenzi B, et al. Among authors: frezza am. Expert Opin Emerg Drugs. 2010 Jun;15(2):237-48. doi: 10.1517/14728211003592108. Expert Opin Emerg Drugs. 2010. PMID: 20465449 Review.
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
Santini D, Vincenzi B, Addeo R, Garufi C, Masi G, Scartozzi M, Mancuso A, Frezza AM, Venditti O, Imperatori M, Schiavon G, Bronte G, Cicero G, Recine F, Maiello E, Cascinu S, Russo A, Falcone A, Tonini G. Santini D, et al. Among authors: frezza am. Ann Oncol. 2012 Sep;23(9):2313-2318. doi: 10.1093/annonc/mdr623. Epub 2012 Mar 5. Ann Oncol. 2012. PMID: 22396447 Free article. Clinical Trial.
93 results